Thursday, September 29, 2022 9:50:45 AM
Recent ADTX News
- Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares • Business Wire • 11/08/2024 01:30:00 PM
- Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders • Business Wire • 11/07/2024 01:30:00 PM
- Appili Therapeutics Announces Results of Special Meeting of Shareholders • GlobeNewswire Inc. • 11/06/2024 10:55:08 PM
- Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem • Business Wire • 11/06/2024 01:30:00 PM
- Evofem Secures Investor Support for Proposed Merger through Voting Agreements • PR Newswire (US) • 11/06/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 09:15:10 PM
- Biopharma Bucking Market Trends on Positive FDA Feedback • AllPennyStocks.com • 10/31/2024 05:00:00 PM
- Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission • Business Wire • 10/31/2024 12:30:00 PM
- Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission • GlobeNewswire Inc. • 10/31/2024 11:15:59 AM
- Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time • Business Wire • 10/30/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:15:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:42:32 PM
- Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives • Business Wire • 10/29/2024 12:15:00 PM
- Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem • Business Wire • 10/28/2024 12:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/25/2024 08:15:31 PM
- Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time • Business Wire • 10/21/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 09:11:38 PM
- Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval • Business Wire • 10/10/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:15:07 PM
- Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time • Business Wire • 10/09/2024 02:52:00 PM
- Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem • Business Wire • 10/08/2024 12:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/07/2024 01:23:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/07/2024 12:54:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:30:09 PM
- Aditxt Delivers Shareholder Update and 2024 Year-End Plan • Business Wire • 10/03/2024 12:15:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM